These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 12479063)
1. [Expression of growth hormone receptor mRNA in hepatocellular carcinoma and matched para-cancer cirrhotic liver tissue]. Wang HT; Wang J; Ou QJ; Liu XP; Chen S Ai Zheng; 2002 Feb; 21(2):146-8. PubMed ID: 12479063 [TBL] [Abstract][Full Text] [Related]
2. [Expression of growth hormone receptor and its mRNA in cirrhotic livers]. Wang H; Chen S; Ou Q; Deng M; Liu X Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):168-71. PubMed ID: 11953152 [TBL] [Abstract][Full Text] [Related]
3. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver. Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708 [TBL] [Abstract][Full Text] [Related]
4. [Expression of growth hormone receptor in hepatocellular carcinoma and its significance]. Liu JP; Wang HT; Ou QJ; Lu YT; Lu HP; Gao JH; Chu ZH; Zhao HY Ai Zheng; 2003 Mar; 22(3):298-301. PubMed ID: 12654191 [TBL] [Abstract][Full Text] [Related]
5. [Expression and clinical significance of Ephrin-A1 in primary hepatocellular carcinoma]. Zhang G; Zhang SJ; Zhao YF; Wu Y; Li Z; Wang JX Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):499-502. PubMed ID: 17686315 [TBL] [Abstract][Full Text] [Related]
6. [Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients]. Zhou Q; Liang LJ; Peng BG; Zhen YY Ai Zheng; 2006 Nov; 25(11):1433-8. PubMed ID: 17094916 [TBL] [Abstract][Full Text] [Related]
7. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China. Dong-Dong L; Xi-Ran Z Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194 [TBL] [Abstract][Full Text] [Related]
8. Expression of SSX-1 and NY-ESO-1 mRNA in tumor tissues and its corresponding peripheral blood expression in patients with hepatocellular carcinoma. Lu Y; Wu LQ; Lü ZH; Wang XJ; Yang JY Chin Med J (Engl); 2007 Jun; 120(12):1042-6. PubMed ID: 17637219 [TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers. Bedossa P; Peltier E; Terris B; Franco D; Poynard T Hepatology; 1995 Mar; 21(3):760-6. PubMed ID: 7875675 [TBL] [Abstract][Full Text] [Related]
10. GADD45-alpha expression in cirrhosis and hepatocellular carcinoma: relationship with DNA repair and proliferation. Gramantieri L; Chieco P; Giovannini C; Lacchini M; Treré D; Grazi GL; Venturi A; Bolondi L Hum Pathol; 2005 Nov; 36(11):1154-62. PubMed ID: 16260267 [TBL] [Abstract][Full Text] [Related]
11. [Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells]. Li BD; Zhao QC; Zhu YT; Zhang FQ; Dou KF Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):458-62. PubMed ID: 16772080 [TBL] [Abstract][Full Text] [Related]
12. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma]. Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066 [TBL] [Abstract][Full Text] [Related]
13. Fetal- and tumor-specific regulation of growth hormone receptor messenger RNA expression in human liver. Zogopoulos G; Albrecht S; Pietsch T; Alpert L; von Schweinitz D; Lefèbvre Y; Goodyer CG Cancer Res; 1996 Jul; 56(13):2949-53. PubMed ID: 8674047 [TBL] [Abstract][Full Text] [Related]
14. [Overexpression and genomic amplification of decoy receptor 3 in hepatocellular carcinoma and significance thereof]. Shen HW; Wu YL; Peng SY Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):744-7. PubMed ID: 12899749 [TBL] [Abstract][Full Text] [Related]
15. [Expression of NET-1 gene and protein in hepatocellular carcinoma and related tissues]. Chen L; Shen AG; Wang GL; Lu P; Li XY Ai Zheng; 2006 Mar; 25(3):320-5. PubMed ID: 16536986 [TBL] [Abstract][Full Text] [Related]
16. Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma. Iavarone M; Lampertico P; Iannuzzi F; Manenti E; Donato MF; Arosio E; Bertolini F; Primignani M; Sangiovanni A; Colombo M J Viral Hepat; 2007 Feb; 14(2):133-9. PubMed ID: 17244253 [TBL] [Abstract][Full Text] [Related]
17. Glutathione and GSH-dependent enzymes in patients with liver cirrhosis and hepatocellular carcinoma. Czeczot H; Scibior D; Skrzycki M; Podsiad M Acta Biochim Pol; 2006; 53(1):237-42. PubMed ID: 16404476 [TBL] [Abstract][Full Text] [Related]
18. Elevated expression of caveolin-1 at protein and mRNA level in human cirrhotic liver: relation with nitric oxide. Yokomori H; Oda M; Yoshimura K; Nomura M; Wakabayashi G; Kitajima M; Ishii H J Gastroenterol; 2003; 38(9):854-60. PubMed ID: 14564631 [TBL] [Abstract][Full Text] [Related]
19. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma]. Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653 [TBL] [Abstract][Full Text] [Related]
20. Receptor activator of nuclear factor-kappaB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis. Sasaki A; Ishikawa K; Haraguchi N; Inoue H; Ishio T; Shibata K; Ohta M; Kitano S; Mori M Ann Surg Oncol; 2007 Mar; 14(3):1191-9. PubMed ID: 17195907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]